Thomas Rupp, Managing Director at Axolabs, and Chris Rombach, Senior Vice President at Asahi Kasei Bioprocess discuss the future of oligonucleotide therapeutics and the challenges associated with large-scale manufacturing while at TIDES 2023 in San Diego, California.